Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-News: NFON AG announces new management team: Andreas Wesselmann becomes CEO, Alexander Beck joins Management Board as CFO
EQS-News: NFON AG announces new management team: Andreas Wesselmann becomes CEO, Alexander Beck joins Management Board as CFO
EQS-News: NFON AG announces new management team: Andreas Wesselmann becomes CEO, Alexander Beck joins Management Board as CFO
EQS-News: Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter
EQS-News: Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter
EQS-News: Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter
EQS-News: The NAGA Group: Research updates from NuWays and SMC point to sustained growth with increasing profitability
EQS-News: The NAGA Group: Research updates from NuWays and SMC point to sustained growth with increasing profitability
EQS-News: The NAGA Group: Research updates from NuWays and SMC point to sustained growth with increasing profitability
EQS-News: NFON AG: Positive business performance in H1 – AI solutions strengthen growth
EQS-News: NFON AG: Positive business performance in H1 – AI solutions strengthen growth
EQS-News: NFON AG: Positive business performance in H1 – AI solutions strengthen growth
EQS-Adhoc: NFON AG revises FY 2025 guidance
EQS-Adhoc: NFON AG revises FY 2025 guidance
EQS-Adhoc: NFON AG revises FY 2025 guidance
EQS-News: STEMMER IMAGING AG: Arne Dehn resigns from his position as CEO
EQS-News: STEMMER IMAGING AG: Arne Dehn resigns from his position as CEO
EQS-News: STEMMER IMAGING AG: Arne Dehn resigns from his position as CEO
EQS-News: The NAGA Group AG Reports Preliminary H1 2025 Results – Revenues and EBITDA Growth Despite Higher Marketing Investments
EQS-News: The NAGA Group AG Reports Preliminary H1 2025 Results – Revenues and EBITDA Growth Despite Higher Marketing Investments
EQS-News: The NAGA Group AG Reports Preliminary H1 2025 Results – Revenues and EBITDA Growth Despite Higher Marketing Investments
EQS-News: Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
EQS-News: Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
EQS-News: Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
EQS-News: STS Group AG's results in line with expectations in the first half of 2025
EQS-News: STS Group AG's results in line with expectations in the first half of 2025
EQS-News: STS Group AG's results in line with expectations in the first half of 2025
EQS-News: In Q2 2025, Westwing delivers strong adjusted EBITDA growth and confirms FY 2025 guidance
EQS-News: In Q2 2025, Westwing delivers strong adjusted EBITDA growth and confirms FY 2025 guidance
EQS-News: In Q2 2025, Westwing delivers strong adjusted EBITDA growth and confirms FY 2025 guidance
EQS-News: Knorr-Bremse Delivers Strong, Compelling H1 Performance
EQS-News: Knorr-Bremse Delivers Strong, Compelling H1 Performance
EQS-News: Knorr-Bremse Delivers Strong, Compelling H1 Performance
EQS-News: DWS with Record Profit in H1, on Track to Reach EPS Target for 2025
EQS-News: DWS with Record Profit in H1, on Track to Reach EPS Target for 2025
EQS-News: DWS with Record Profit in H1, on Track to Reach EPS Target for 2025
EQS-News: Term of office extended for Dr Andreas Hoerning as CEO of Westwing Group SE
EQS-News: Term of office extended for Dr Andreas Hoerning as CEO of Westwing Group SE
EQS-News: Term of office extended for Dr Andreas Hoerning as CEO of Westwing Group SE
EQS-News: The NAGA Group: Research update from SMC available – “BUY” recommendation confirmed and price target raised
EQS-News: The NAGA Group: Research update from SMC available – “BUY” recommendation confirmed and price target raised
EQS-News: The NAGA Group: Research update from SMC available – “BUY” recommendation confirmed and price target raised
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share
EQS-News: NFON AG: Annual General Meeting 2025 underscores claim to leadership in AI-based business communication
EQS-News: NFON AG: Annual General Meeting 2025 underscores claim to leadership in AI-based business communication
EQS-News: NFON AG: Annual General Meeting 2025 underscores claim to leadership in AI-based business communication
EQS-News: Westwing expands across Europe
EQS-News: Westwing expands across Europe
EQS-News: Westwing expands across Europe
EQS-News: The NAGA Group: Research update from NuWays available – price target and “BUY” recommendation confirmed
EQS-News: The NAGA Group: Research update from NuWays available – price target and “BUY” recommendation confirmed
EQS-News: The NAGA Group: Research update from NuWays available – price target and “BUY” recommendation confirmed
EQS-News: The NAGA Group AG Outperforms Preliminary Results with 2024 Audited Consolidated Financial Statements – Concludes Transition Year on Strong Footing
EQS-News: The NAGA Group AG Outperforms Preliminary Results with 2024 Audited Consolidated Financial Statements – Concludes Transition Year on Strong Footing
EQS-News: The NAGA Group AG Outperforms Preliminary Results with 2024 Audited Consolidated Financial Statements – Concludes Transition Year on Strong Footing
EQS-News: The NAGA Group: Research update from SMC available – “BUY” recommendation confirmed
EQS-News: The NAGA Group: Research update from SMC available – “BUY” recommendation confirmed
EQS-News: The NAGA Group: Research update from SMC available – “BUY” recommendation confirmed
EQS-News: NAGA Group AG Publishes Q1 2025 Results And Expands Capital Market Activities With Regular Monthly Updates
EQS-News: NAGA Group AG Publishes Q1 2025 Results And Expands Capital Market Activities With Regular Monthly Updates
EQS-News: NAGA Group AG Publishes Q1 2025 Results And Expands Capital Market Activities With Regular Monthly Updates
EQS-News: Solid start to the year for NFON – growth driven by AI and recurring revenue 
EQS-News: Solid start to the year for NFON – growth driven by AI and recurring revenue 
EQS-News: Solid start to the year for NFON – growth driven by AI and recurring revenue 
EQS-News: Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance
EQS-News: Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance
EQS-News: Dermapharm Holding SE performs in line with projections in Q1 2025, confirms full-year guidance
EQS-News: The NAGA Group Accelerates Platform Expansion and Strengthens User Engagement in Q1 2025
EQS-News: The NAGA Group Accelerates Platform Expansion and Strengthens User Engagement in Q1 2025
EQS-News: The NAGA Group Accelerates Platform Expansion and Strengthens User Engagement in Q1 2025
EQS-News: Westwing achieved 8% adjusted EBITDA margin in Q1 2025, up 3 percentage points year-over-year
EQS-News: Westwing achieved 8% adjusted EBITDA margin in Q1 2025, up 3 percentage points year-over-year
EQS-News: Westwing achieved 8% adjusted EBITDA margin in Q1 2025, up 3 percentage points year-over-year